Fractyl Labs , a Lexington, Massachusetts-based start-up establishing treatments for diabetes, has actually raised $44 million in Series D funding from a multitude of VC companies, consisting of GV, True Ventures, the IDO Fund, General Catalyst, Bessemer Venture Partners, Domain Associates, Mithril Capital Management, Emergent Medical Partners, L.P., and Deerfield Management Company, L.P. Fractyl has […]